Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Clinical Correlations of Lipid Profiles with the Age and Gender in the Coronary Artery Disease Patients: A Study of 3878 CAD Patients from India

Author(s): Rashid Mir*, Imadeldin Elfaki, Ehab A.M. Frah, Khalid J. Alzahrani, Mohammad Muzaffar Mir and Shaheena Banu

Volume 22, Issue 4, 2022

Published on: 18 April, 2022

Page: [440 - 452] Pages: 13

DOI: 10.2174/1871530322666220304110306

Price: $65

Abstract

Background: Cardiovascular diseases (CVDs) are crucial cause of death and hospitalization all over the world including India. The CVDs including the coronary artery disease (CAD) are developed by the interaction of genetic and environmental factors. Hyperlipidemia is a traditional risk factor for CVD.

Aim: The aim of this study was to study the clinical correlations of lipid profiles with the age and gender in the Coronary Artery Disease Patients:

Methods: In this study, we have investigated the effect of age and sex on in lipid profile in 3878 (1171 females and 2707 males) CAD patients from India.

Results: The plasma TG was higher in males than in females regardless of the age. Results showed that CAD female patients had significantly increased HDL-C than their aged matched males. Moreover, the plasma TC and LDL-C were significantly higher in males than females until age 40 years. Then after the age of 40 years, TC and LDL-C become significantly higher in females than in males. In addition, we found that more than 85% of CAD cases were <55 years old, and about 30% of CAD cases had normal lipid profile.

Conclusion: We conclude that elderly females are at a greater risk for CAD than males. Moreover, there were no significant differences in CVDs causes between nonelderly and elderly females. In addition, a higher percentage of cases were premature CAD, and 30% of CAD may be caused by loci that are not related to lipid metabolism.

Keywords: Coronary artery disease, cardiovascular disease, lipids profile, dyslipidemia, hyperlipidemia, hypercholesterolemia.

« Previous
Graphical Abstract

[1]
Hajar, R. Framingham contribution to cardiovascular disease. Heart Views, 2016, 17(2), 78-81.
[http://dx.doi.org/10.4103/1995-705X.185130] [PMID: 27512540]
[2]
Abdul-Aziz, A.A.; Desikan, P.; Prabhakaran, D.; Schroeder, L.F. Tackling the burden of cardiovascular diseases in India. Circ. Cardiovasc. Qual. Outcomes, 2019, 12(4), e005195.
[http://dx.doi.org/10.1161/CIRCOUTCOMES.118.005195] [PMID: 30917685]
[3]
Nelson, R.H. Hyperlipidemia as a risk factor for cardiovascular disease. Prim. Care, 2013, 40(1), 195-211.
[http://dx.doi.org/10.1016/j.pop.2012.11.003] [PMID: 23402469]
[4]
Elfaki, I.; Mir, R.; Almutairi, F.M.; Duhier, F.M.A. Cytochrome P450: Polymorphisms and roles in cancer, diabetes and atherosclerosis. Asian Pac. J. Cancer Prev., 2018, 19(8), 2057-2070.
[PMID: 30139042]
[5]
Jha, C.K.; Mir, R.; Elfaki, I.; Javid, J.; Babakr, A.T.; Banu, S.; Chahal, S.M.S. Evaluation of the association of omentin 1 rs2274907 A>T and rs2274908 G>A gene polymorphisms with coronary artery disease in Indian population: A case control study. J. Pers. Med., 2019, 9(2), 30.
[http://dx.doi.org/10.3390/jpm9020030] [PMID: 31174318]
[6]
Jha, C.K.; Mir, R.; Banu, S.; Elfaki, I.; Chahal, S.M.S. Heterozosity in LDLR rs2228671 and LDLR rs72658855 are associated with increased risk of developing Coronary artery disease in India -A case control study. Endocr. Metab. Immune Disord. Drug Targets, 2020, 20(3), 388-399.
[http://dx.doi.org/10.2174/1871530319666191015164505] [PMID: 31613733]
[7]
Mir, R.; Jha, C.K.; Elfaki, I.; Javid, J.; Rehman, S.; Khullar, N.; Banu, S.; Chahal, S.M.S. incidence of MicroR-4513C/T gene variability in coronary artery disease - A case-control study. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(8), 1216-1223.
[http://dx.doi.org/10.2174/1871530319666190417111940] [PMID: 31038082]
[8]
Jha, C.K.; Mir, R.; Elfaki, I.; Banu, S.; Chahal, S.M.S. LDLR gene polymorphisms (rs5925 and rs1529729) are associated with susceptibility to coronary artery disease in a South Indian population. Med. Sci. (Basel), 2019, 7(7), 80.
[9]
Kessler, T.; Vilne, B.; Schunkert, H. The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease. EMBO Mol. Med., 2016, 8(7), 688-701.
[http://dx.doi.org/10.15252/emmm.201506174] [PMID: 27189168]
[10]
Elfaki, I.; Mir, R.; Mir, M.M.; AbuDuhier, F.M.; Babakr, A.T.; Barnawi, J. Potential impact of microrna gene polymorphisms in the pathogenesis of diabetes and atherosclerotic cardiovascular disease. J. Pers. Med., 2019, 9(4), E51.
[http://dx.doi.org/10.3390/jpm9040051] [PMID: 31775219]
[11]
Elfaki, I.; Mir, R.; Abu-Duhier, F.M.; Jha, C.K.; Ahmad Al-Alawy, A.I.; Babakr, A.T.; Habib, S.A.E. Analysis of the potential association of drug-metabolizing enzymes CYP2C9*3 and CYP2C19*3 gene variations with type 2 diabetes: A case-control study. Curr. Drug Metab., 2020, 21(14), 1152-1160.
[http://dx.doi.org/10.2174/1389200221999201027200931] [PMID: 33115391]
[12]
Psaltopoulou, T.; Hatzis, G.; Papageorgiou, N.; Androulakis, E.; Briasoulis, A.; Tousoulis, D. Socioeconomic status and risk factors for cardiovascular disease: Impact of dietary mediators. Hellenic J. Cardiol., 2017, 58(1), 32-42.
[http://dx.doi.org/10.1016/j.hjc.2017.01.022] [PMID: 28161284]
[13]
Félix-Redondo, F.J.; Grau, M.; Fernández-Bergés, D. Cholesterol and cardiovascular disease in the elderly. Facts and gaps. Aging Dis., 2013, 4(3), 154-169.
[PMID: 23730531]
[14]
Lee, J.S.; Chang, P.Y.; Zhang, Y.; Kizer, J.R.; Best, L.G.; Howard, B.V. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: The strong heart study. Diabetes Care, 2017, 40(4), 529-537.
[http://dx.doi.org/10.2337/dc16-1958] [PMID: 28122840]
[15]
Giammanco, A.; Cefalù, A.B.; Noto, D.; Averna, M.R. The pathophysiology of intestinal lipoprotein production. Front. Physiol., 2015, 6, 61.
[http://dx.doi.org/10.3389/fphys.2015.00061] [PMID: 25852563]
[16]
Röhrl, C.; Stangl, H. HDL endocytosis and resecretion. Biochim. Biophys. Acta, 2013, 1831(11), 1626-1633.
[http://dx.doi.org/10.1016/j.bbalip.2013.07.014] [PMID: 23939397]
[17]
Kolovou, G.D.; Anagnostopoulou, K.K.; Damaskos, D.S.; Bilianou, H.I.; Mihas, C.; Milionis, H.J.; Kostakou, P.M.; Cokkinos, D.V. Gender differences in the lipid profile of dyslipidemic subjects. Eur. J. Intern. Med., 2009, 20(2), 145-151.
[http://dx.doi.org/10.1016/j.ejim.2008.06.011] [PMID: 19327602]
[18]
Zhao, P.; Liu, S.; Zhong, Z.; Liu, J. Age- and sex-related difference of lipid profile in patients with ischemic stroke in China. Medicine (Baltimore), 2018, 97(23), e10930.
[http://dx.doi.org/10.1097/MD.0000000000010930] [PMID: 29879034]
[19]
Milyani, A.A.; Al-Agha, A.E. The effect of body mass index and gender on lipid profile in children and adolescents in Saudi Arabia. Ann. Afr. Med., 2019, 18(1), 42-46.
[http://dx.doi.org/10.4103/aam.aam_17_18] [PMID: 30729932]
[20]
Kumar, K.R.; Ranganath, V.; Naik, R.; Banu, S.; Nichani, A.S. Assessment of high-sensitivity C-reactive protein and lipid levels in healthy adults and patients with coronary artery disease, with and without periodontitis-a cross-sectional study. J. Periodontal Res., 2014, 49(6), 836-844.
[http://dx.doi.org/10.1111/jre.12172] [PMID: 24620793]
[21]
Rodgers, J.L.; Jones, J.; Bolleddu, S.I.; Vanthenapalli, S.; Rodgers, L.E.; Shah, K.; Karia, K.; Panguluri, S.K. Cardiovascular risks associated with gender and aging. J. Cardiovasc. Dev. Dis., 2019, 6(2), E19.
[http://dx.doi.org/10.3390/jcdd6020019] [PMID: 31035613]
[22]
Wang, X.; Magkos, F.; Mittendorfer, B. Sex differences in lipid and lipoprotein metabolism: It’s not just about sex hormones. J. Clin. Endocrinol. Metab., 2011, 96(4), 885-893.
[http://dx.doi.org/10.1210/jc.2010-2061] [PMID: 21474685]
[23]
Resanovic, I.; Rizzo, M.; Zafirovic, S.; Bjelogrlic, P.; Perovic, M.; Savic, K.; Patti, A.M.; Isenovic, R.E. Anti-atherogenic effects of 17β-estradiol. Horm. Metab. Res., 2013, 45(10), 701-708.
[http://dx.doi.org/10.1055/s-0033-1343478] [PMID: 23681753]
[24]
Peng, J.; Luo, F.; Ruan, G.; Peng, R.; Li, X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis., 2017, 16(1), 233.
[http://dx.doi.org/10.1186/s12944-017-0625-0] [PMID: 29212549]
[25]
Mohammad, A.M.; Jehangeer, H.I.; Shaikhow, S.K. Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq. BMC Cardiovasc. Disord., 2015, 15, 155.
[http://dx.doi.org/10.1186/s12872-015-0145-7] [PMID: 26582255]
[26]
Sadeghi, R.; Adnani, N.; Erfanifar, A.; Gachkar, L.; Maghsoomi, Z. Premature coronary heart disease and traditional risk factors-can we do better? Int. Cardiovasc. Res. J., 2013, 7(2), 46-50.
[PMID: 24757620]
[27]
Scheuner, M.T. Genetic evaluation for coronary artery disease. Genet. Med., 2003, 5(4), 269-285.
[http://dx.doi.org/10.1097/01.GIM.0000079364.98247.26] [PMID: 12865756]
[28]
Ibrahim, M. Lipid profile in Egyptian patients with coronary artery disease. Egypt. Heart J., 2013, 65, 79-85.
[http://dx.doi.org/10.1016/j.ehj.2012.08.005]
[29]
Sivapalaratnam, S.; Motazacker, M.M.; Maiwald, S.; Hovingh, G.K.; Kastelein, J.J.; Levi, M.; Trip, M.D.; Dallinga-Thie, G.M. Genome-wide association studies in atherosclerosis. Curr. Atheroscler. Rep., 2011, 13(3), 225-232.
[http://dx.doi.org/10.1007/s11883-011-0173-4] [PMID: 21369780]
[30]
Fava, C.; Montagnana, M. Atherosclerosis is an inflammatory disease which lacks a common anti-inflammatory therapy: How human genetics can help to this issue. A narrative review. Front. Pharmacol., 2018, 9, 55.
[http://dx.doi.org/10.3389/fphar.2018.00055] [PMID: 29467655]

Rights & Permissions Print Cite
Article Metrics
16
1
© 2024 Bentham Science Publishers | Privacy Policy